Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse
| Status: | Completed |
|---|---|
| Conditions: | Psychiatric, Pulmonary |
| Therapuetic Areas: | Psychiatry / Psychology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 50 |
| Updated: | 2/1/2019 |
| Start Date: | December 2007 |
| End Date: | January 2015 |
Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse With Methadone Maintained Individuals
We are testing to see if Galantamine, a learning enhancing medication, will help methadone
maintained cocaine abusers with their learning and memory specific to CBT using an innovative
CBT computer program.
maintained cocaine abusers with their learning and memory specific to CBT using an innovative
CBT computer program.
We are proposing a randomized double blind clinical trial of galantamine and our innovative
computer-assisted version of CBT, alone and in combination, to improve treatment outcome and
cognitive functioning among cocaine users. The proposed study will be the first to evaluate a
cognitive enhancing medication as a means of enhancing the effects of an extremely promising
empirically validated behavioral therapy for addiction, and hence bridge cognitive
neuroscience and behavioral therapies development.
The aim is to conduct a 12 week randomized placebo controlled trial, using a 2x2 factorial
model, that will evaluate the efficacy of adding computer assisted training in CBT
("CBT4CBT") and galantamine to standard treatment for 160 cocaine abusing or dependent
methadone-maintained individuals. Participants will be randomized to (1) standard treatment
(TAU) plus placebo, (2) TAU plus galantamine, (3) TAU plus CBT4CBT plus placebo, or (4) TAU
plus CBT4CBT plus galantamine.
computer-assisted version of CBT, alone and in combination, to improve treatment outcome and
cognitive functioning among cocaine users. The proposed study will be the first to evaluate a
cognitive enhancing medication as a means of enhancing the effects of an extremely promising
empirically validated behavioral therapy for addiction, and hence bridge cognitive
neuroscience and behavioral therapies development.
The aim is to conduct a 12 week randomized placebo controlled trial, using a 2x2 factorial
model, that will evaluate the efficacy of adding computer assisted training in CBT
("CBT4CBT") and galantamine to standard treatment for 160 cocaine abusing or dependent
methadone-maintained individuals. Participants will be randomized to (1) standard treatment
(TAU) plus placebo, (2) TAU plus galantamine, (3) TAU plus CBT4CBT plus placebo, or (4) TAU
plus CBT4CBT plus galantamine.
Inclusion Criteria:
- Males and females between ages of 18 and 50
- Enrolled in RNP methadone program and stable on methadone for at least 3 weeks
- Current cocaine abuse or dependence according to DSM-IV criteria
- No current medical problems and normal ECG
- If female, not currently pregnant or breast feeding and using reliable birth control
- Fluent in English and have at least a 6th grade reading level
- Can commit to 12 weeks of treatment and are willing to be randomized
Exclusion Criteria:
- Current major psychiatric illness including mood, psychotic or anxiety disorder
- History of major medical illnesses including asthma, chronic obstructive lung disease,
gastrointestinal ulcer, hepatic or renal impairment, cardiac rhythm disturbances
- Use of medications including beta blockers and NASAIDs
- Known allergy to Galantamine
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials